Abstract
In 2021, the American Society of Reproductive Medicine recommended case-by-case consideration of donors heterozygous for recessive conditions that confer health risks to carriers.1 This study describes a US sperm bank’s experience with determining suitability of donor applicants identified as carriers at-risk for symptoms.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
